FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Peter Stålberg

Research Profile

Disorders

Chemicals & Drugs

Procedures

Physiology

Living Beings

Mouse

Concepts & Ideas

Devices

Oligonucleotide Array Sequence Analysis

Anatomy

Tumor Cell Line

Co-author Network

Publications

TOP 3
Maria Annerbo; Peter Stålberg; Per Hellman
Management of Grave's disease is improved by total thyroidectomy.
Olov Norlén; Peter Stålberg; Per Hellman; Johan Krause; Anders Nilsson; Anders Sundin
11C-5-hydroxytryptophan positron emission tomography after radiofrequency ablation of neuroendocrine tumor liver metastases.
Margareta Halin Lejonklou; Andreea Barbu; Peter Stålberg; Britt Skogseid
Accelerated proliferation and differential global gene expression in pancreatic islets of five-week-old heterozygous Men1 mice: Men1 is a haploinsufficient suppressor.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Peter Stålberg (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Maria Annerbo; Peter Stålberg; Per Hellman
Management of Grave's disease is improved by total thyroidectomy.
World journal of surgery 2012;36(8):1943-6.
2012: Olov Norlén; Peter Stålberg; Per Hellman; Johan Krause; Anders Nilsson; Anders Sundin
11C-5-hydroxytryptophan positron emission tomography after radiofrequency ablation of neuroendocrine tumor liver metastases.
Nuclear medicine and biology 2012;39(6):883-90.
2012: Margareta Halin Lejonklou; Andreea Barbu; Peter Stålberg; Britt Skogseid
Accelerated proliferation and differential global gene expression in pancreatic islets of five-week-old heterozygous Men1 mice: Men1 is a haploinsufficient suppressor.
Endocrinology 2012;153(6):2588-98.
2012: Sara Ekeblad; Margareta Halin Lejonklou; Peter Stålberg; Britt Skogseid
Prognostic relevance of survivin in pancreatic endocrine tumors.
World journal of surgery 2012;36(6):1411-8.
2012: Olov Norlén; Peter Stålberg; Kjell Oberg; John Eriksson; Jakob Hedberg; Per Hellman; Ola Hessman; Eva Tiensuu Janson; Göran Akerström
Long-term results of surgery for small intestinal neuroendocrine tumors at a tertiary referral center.
World journal of surgery 2012;36(6):1419-31.
2012: Göran Akerström; Peter Stålberg; Per Hellman
Surgical management of pancreatico-duodenal tumors in multiple endocrine neoplasia syndrome type 1.
Clinics (São Paulo, Brazil) 2012;67 Suppl 1():173-8.
2011: Katarina Edfeldt; Per Hellman; Gunnar Westin; Göran Akerström; Peyman Björklund; Peter Stålberg
Different gene expression profiles in metastasizing midgut carcinoid tumors.
Endocrine-related cancer 2011;18(4):479-89.
2009: Göran Akerström; Peter Stålberg
Surgical management of MEN-1 and -2: state of the art.
The Surgical clinics of North America 2009;89(5):1047-68.
2009: Juan Lopez-Egido; Yi Wang; Malin Grönberg; Per Grimfjärd; Shu Wang; Peter Stålberg; Britt Skogseid
Differentially regulated genes in MEN1-transfected BON cells using RT-differential display and oligonucleotide microarrays.
Anticancer research 2009;29(6):1859-66.
2008: Peter Stålberg; Anna Svensson; Ola Hessman; Göran Akerström; Per Hellman
Surgical treatment of Graves' disease: evidence-based approach.
World journal of surgery 2008;32(7):1269-77.
2008: Terese Johansson; Margareta Halin Lejonklou; Sara Ekeblad; Peter Stålberg; Britt Skogseid
Lack of nuclear expression of hairy and enhancer of split-1 (HES1) in pancreatic endocrine tumors.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 2008;40(5):354-9.
2008: Ola Hessman; Peter Stålberg; Anders Sundin; Ulrike Garske; C Rudberg; Lars-Gunnar Eriksson; Per Hellman; Göran Akerström
High success rate of parathyroid reoperation may be achieved with improved localization diagnosis.
World journal of surgery 2008;32(5):774-81; discussion 782-3.
2008: John Eriksson; Peter Stålberg; Anders Nilsson; Johan Krause; Christina Lundberg; Britt Skogseid; Dan Granberg; Barbro Eriksson; Göran Akerström; Per Hellman
Surgery and radiofrequency ablation for treatment of liver metastases from midgut and foregut carcinoids and endocrine pancreatic tumors.
World journal of surgery 2008;32(5):930-8.
2007: Sara Ekeblad; Margareta Halin Lejonklou; Per Grimfjärd; Terese Johansson; Barbro Eriksson; Lars Grimelius; Mats Stridsberg; Peter Stålberg; Britt Skogseid
Co-expression of ghrelin and its receptor in pancreatic endocrine tumours.
Clinical endocrinology 2007;66(1):115-22.
2006: Peter Stålberg; Mårten Santesson; Sara Ekeblad; Margareta Halin Lejonklou; Britt Skogseid
Recognizing genes differentially regulated in vitro by the multiple endocrine neoplasia type 1 (MEN1) gene, using RNA interference and oligonucleotide microarrays.
Surgery 2006;140(6):921-9; discussion 929-31.
2006: Sara Ekeblad; Bengt Nilsson; Margareta Halin Lejonklou; Terese Johansson; Peter Stålberg; Ola Nilsson; Håkan Ahlman; Britt Skogseid
Gastrointestinal stromal tumors express the orexigen ghrelin.
Endocrine-related cancer 2006;13(3):963-70.
2004: Peter Stålberg; Per Grimfjärd; Mårten Santesson; Yinghua Zhou; Daniel Lindberg; Anders Gobl; Kjell Oberg; Gunnar Westin; Jonas Rastad; Shu Wang; Britt Skogseid
Transfection of the multiple endocrine neoplasia type 1 gene to a human endocrine pancreatic tumor cell line inhibits cell growth and affects expression of JunD, delta-like protein 1/preadipocyte factor-1, proliferating cell nuclear antigen, and QM/Jif-1.
The Journal of clinical endocrinology and metabolism 2004;89(5):2326-37.
2003: Peter Stålberg; Dan Granberg; Tobias Carling; Erik Wilander; Barbro Eriksson; Anders Gobl; Göran Akerström; Jonas Rastad; Irvin M Modlin; Kjell Oberg; Britt Skogseid
In situ RNA-RNA hybridisation of phospholipase C beta 3 shows lack of expression in neuroendocrine tumours.
Anticancer research 2003;23(3B):2227-32.
2001: Peter Stålberg; Juan Lopez-Egido; S Wang; Anders Gobl; Kjell Oberg; Britt Skogseid
Differentially expressed cDNAs in PLCbeta3-induced tumor suppression in a human endocrine pancreatic tumor cell line: activation of the human mismatch repair protein 3 gene.
Biochemical and biophysical research communications 2001;281(1):227-31.
2000: S Wang; Agneta Lukinius; Y Zhou; Peter Stålberg; Anders Gobl; K Oberg; B Skogseid
Subcellular distribution of phospholipase C isoforms in rodent pancreas and gastric mucosa.
Endocrinology 2000;141(7):2589-93.
1999: Peter Stålberg; S Wang; C Larsson; Günther Weber; Kjell Oberg; Anders Gobl; Britt Skogseid
Suppression of the neoplastic phenotype by transfection of phospholipase C beta 3 to neuroendocrine tumor cells.
FEBS letters 1999;450(3):210-6.
1998: S Wang; Samuel Gebre-Medhin; Christer Betsholtz; Peter Stålberg; Y Zhou; C Larsson; Günther Weber; R Feinstein; Kjell Oberg; Anders Gobl; Britt Skogseid
Targeted disruption of the mouse phospholipase C beta3 gene results in early embryonic lethality.
FEBS letters 1998;441(2):261-5.